Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iron Sucrose In The Treatment of Restless Legs Syndrome (RLS): The Safety of Three Dose Regimens as Evaluated by Clinical Assessments

NCT00895232 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT00895232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00895232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iron Sucrose In The Treatment of Restless Legs Syndrome (RLS): The Safety of Three Dose Regimens as Evaluated by Clinical Assessments
Lead sponsor
American Regent, Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
November 30, 2005
Enrollment
21 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome